Vitiligo

The Lancet

Volumn 386, Issue 9988, 2015, Pages 74-84

  Ezzedine, Khaled ^a,d   Eleftheriadou, Viktoria ^b   Whitton, Maxine ^b   Van Geel, Nanja ^c  

^a HÔPITAL PELLEGRIN   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^d GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN INHIBITOR; CORTICOSTEROID; DERMATOLOGICAL AGENT; GLUCOCORTICOID; MELAGENINA; STEROID; TACROLIMUS; UNCLASSIFIED DRUG; VITAMIN D;

CELL TRANSPLANTATION; CONFERENCE PAPER; DISEASE CLASSIFICATION; EARLY INTERVENTION; HUMAN; PATHOPHYSIOLOGY; PATIENT EDUCATION; PHOTOTHERAPY; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SKIN GRAFT; SOCIAL PSYCHOLOGY; SYSTEMATIC REVIEW (TOPIC); ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; VITILIGO; IMMUNOLOGY; MENTAL DISORDERS; PROCEDURES; PSYCHOLOGY;

DERMATOLOGIC AGENTS; HUMANS; MENTAL DISORDERS; PHOTOTHERAPY; VITILIGO;

EID: 84937522731     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(14)60763-7     Document Type: Conference Paper

References (119)

1. BK Nair Vitiligo - a retrospect Int J Dermatol 17 1978 755 757
2. Y Gauthier, L Benzekri Historical aspects M Picardo A Taïeb Vitiligo 2010 Springer Verlag Heidelberg 3 9
3. RV Koranne, KG Sachdeva Vitiligo Int J Dermatol 27 1988 676 681
4. AK Panda The medico historical perspective of vitiligo (Switra) Bull Indian Inst Hist Med Hyderabad 35 2005 41 46
5. K Ezzedine, HW Lim, T Suzuki et al. Revised classification/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference Pigment Cell Melanoma Res 25 2012 E1 13
6. J Howitz, H Brodthagen, M Schwartz, K Thomsen Prevalence of vitiligo. Epidemiological survey on the Isle of Bornholm, Denmark Arch Dermatol 113 1977 47 52
7. PN Behl, RK Bhatia 400 cases of vitiligo. A clinico-therapeutic analysis Indian J Dermatol 17 1972 51 56
8. VN Sehgal, G Srivastava Vitiligo: compendium of clinico-epidemiological features Indian J Dermatol Venereol Leprol 73 2007 149 156
9. AM Boisseau-Garsaud, P Garsaud, D Calès-Quist, R Hélénon, C Quénéhervé, RC Claire Epidemiology of vitiligo in the French West Indies (Isle of Martinique) Int J Dermatol 39 2000 18 20
10. M Singh, G Singh, AJ Kanwar, MS Belhaj Clinical pattern of vitiligo in Libya Int J Dermatol 24 1985 233 235
11. A Alikhan, LM Felsten, M Daly, V Petronic-Rosic Vitiligo: a comprehensive overview Part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up J Am Acad Dermatol 65 2011 473 491
12. SK Das, PP Majumder, R Chakraborty, TK Majumdar, B Haldar Studies on vitiligo. I. Epidemiological profile in Calcutta, India Genet Epidemiol 2 1985 71 78
13. K Ezzedine, A Diallo, C Léauté-Labrèze et al. Pre- vs. post-pubertal onset of vitiligo: multivariate analysis indicates atopic diathesis association in pre-pubertal onset vitiligo Br J Dermatol 167 2012 490 495
14. E Nicolaidou, C Antoniou, A Miniati et al. Childhood- and later-onset vitiligo have diverse epidemiologic and clinical characteristics J Am Acad Dermatol 66 2012 954 958
15. RM Halder Childhood vitiligo Clin Dermatol 15 1997 899 906
16. RM Halder, PE Grimes, CA Cowan, JA Enterline, SG Chakrabarti, JA Kenney Jr Childhood vitiligo J Am Acad Dermatol 16 1987 948 954
17. Z Hu, JB Liu, SS Ma, S Yang, XJ Zhang Profile of childhood vitiligo in China: an analysis of 541 patients Pediatr Dermatol 23 2006 114 116
18. NB Silverberg Update on childhood vitiligo Curr Opin Pediatr 22 2010 445 452
19. SK Hann, HJ Lee Segmental vitiligo: clinical findings in 208 patients J Am Acad Dermatol 35 1996 671 674
20. K Al-Refu Vitiligo in children: a clinical-epidemiologic study in Jordan Pediatr Dermatol 29 2012 114 115
21. C Krüger, KU Schallreuter A review of the worldwide prevalence of vitiligo in children/adolescents and adults Int J Dermatol 51 2012 1206 1212
22. N van Geel, I Mollet, L Brochez et al. New insights in segmental vitiligo: case report and review of theories Br J Dermatol 166 2012 240 246
23. A Taïeb, M Picardo the VETF Members The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force Pigment Cell Res 20 2007 27 35
24. A Taïeb, M Picardo Clinical practice. Vitiligo N Engl J Med 360 2009 160 169
25. K Ezzedine, A Le Thuaut, T Jouary, F Ballanger, A Taieb, S Bastuji-Garin Latent class analysis of a series of 717 patients with vitiligo allows the identification of two clinical subtypes Pigment Cell Melanoma Res 27 2014 134 139
26. K Ezzedine, Y Gauthier, C Léauté-Labrèze et al. Segmental vitiligo associated with generalized vitiligo (mixed vitiligo): a retrospective case series of 19 patients J Am Acad Dermatol 65 2011 965 971
27. K Ezzedine, E Amazan, J Séneschal et al. Follicular vitiligo: a new form of vitiligo Pigment Cell Melanoma Res 25 2012 527 529
28. IC Le Poole, PK Das, RM van den Wijngaard, JD Bos, W Westerhof Review of the etiopathomechanism of vitiligo: a convergence theory Exp Dermatol 2 1993 145 153
29. M Sandoval-Cruz, M García-Carrasco, R Sánchez-Porras et al. Immunopathogenesis of vitiligo Autoimmun Rev 10 2011 762 765
30. JM Richmond, ML Frisoli, JE Harris Innate immune mechanisms in vitiligo: danger from within Curr Opin Immunol 25 2013 676 682
31. A Gey, A Diallo, J Seneschal et al. Autoimmune thyroid disease in vitiligo: multivariate analysis indicates intricate pathomechanisms Br J Dermatol 168 2013 756 761
32. A Alkhateeb, PR Fain, A Thody, DC Bennett, RA Spritz Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families Pigment Cell Res 16 2003 208 214
33. KU Schallreuter, R Lemke, O Brandt et al. Vitiligo and other diseases: coexistence or true association? Hamburg study on 321 patients Dermatology 188 1994 269 275
34. S Dogra, D Parsad, S Handa, AJ Kanwar Late onset vitiligo: a study of 182 patients Int J Dermatol 44 2005 193 196
35. SA Birlea, PR Fain, RA Spritz A Romanian population isolate with high frequency of vitiligo and associated autoimmune diseases Arch Dermatol 144 2008 310 316
36. K Ezzedine, A Diallo, C Léauté-Labrèze et al. Halo nevi association in nonsegmental vitiligo affects age at onset and depigmentation pattern Arch Dermatol 148 2012 497 502
37. JB Liu, M Li, S Yang et al. Clinical profiles of vitiligo in China: an analysis of 3742 patients Clin Exp Dermatol 30 2005 327 331
38. RA Spritz Shared genetic relationships underlying generalized vitiligo and autoimmune thyroid disease Thyroid 20 2010 745 754
39. Y Jin, SA Birlea, PR Fain et al. Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo N Engl J Med 362 2010 1686 1697
40. RA Spritz Molecular genetics of oculocutaneous albinism Hum Mol Genet 3 1994 1469 1475
41. RA Spritz, VJ Hearing Jr Genetic disorders of pigmentation Adv Hum Genet 22 1994 1 45
42. N Rezaei, NG Gavalas, AP Weetman, EH Kemp Autoimmunity as an aetiological factor in vitiligo J Eur Acad Dermatol Venereol 21 2007 865 876
43. SA Birlea, Y Jin, DC Bennett et al. Comprehensive association analysis of candidate genes for generalized vitiligo supports XBP1, FOXP3, and TSLP J Invest Dermatol 131 2011 371 381
44. RA Spritz The genetics of generalized vitiligo: autoimmune pathways and an inverse relationship with malignant melanoma Genome Med 2 2010 78
45. RA Spritz Six decades of vitiligo genetics: genome-wide studies provide insights into autoimmune pathogenesis J Invest Dermatol 132 2012 268 273
46. Y Jin, CM Mailloux, K Gowan et al. NALP1 in vitiligo-associated multiple autoimmune disease N Engl J Med 356 2007 1216 1225
47. Y Jin, SA Birlea, PR Fain et al. Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo Nat Genet 44 2012 676 680
48. JA Mosenson, A Zloza, J Klarquist, AJ Barfuss, JA Guevara-Patino, IC Poole HSP70i is a critical component of the immune response leading to vitiligo Pigment Cell Melanoma Res 25 2012 88 98
49. JA Mosenson, A Zloza, JD Nieland et al. Mutant HSP70 reverses autoimmune depigmentation in vitiligo Sci Transl Med 5 2013 74ra28
50. C Bang, T Thum Exosomes: new players in cell-cell communication Int J Biochem Cell Biol 44 2012 2060 2064
51. JG van den Boorn, DI Picavet, PF van Swieten et al. Skin-depigmenting agent monobenzone induces potent T-cell autoimmunity toward pigmented cells by tyrosinase haptenation and melanosome autophagy J Invest Dermatol 131 2011 1240 1251
52. K Jimbow, H Chen, JS Park, PD Thomas Increased sensitivity of melanocytes to oxidative stress and abnormal expression of tyrosinase-related protein in vitiligo Br J Dermatol 144 2001 55 65
53. V Maresca, M Roccella, F Roccella et al. Increased sensitivity to peroxidative agents as a possible pathogenic factor of melanocyte damage in vitiligo J Invest Dermatol 109 1997 310 313
54. N Puri, M Mojamdar, A Ramaiah In vitro growth characteristics of melanocytes obtained from adult normal and vitiligo subjects J Invest Dermatol 88 1987 434 438
55. E Noessner, R Gastpar, V Milani et al. Tumor-derived heat shock protein 70 peptide complexes are cross-presented by human dendritic cells J Immunol 169 2002 5424 5432
56. JG van den Boorn, D Konijnenberg, TA Dellemijn et al. Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients J Invest Dermatol 129 2009 2220 2232
57. Y Lili, W Yi, Y Ji, S Yue, S Weimin, L Ming Global activation of CD8+ cytotoxic T lymphocytes correlates with an impairment in regulatory T cells in patients with generalized vitiligo PLoS One 7 2012 e37513
58. L Zhou, K Li, YL Shi et al. Systemic analyses of immunophenotypes of peripheral T cells in non-segmental vitiligo: implication of defective natural killer T cells Pigment Cell Melanoma Res 25 2012 602 611
59. M Dwivedi, NC Laddha, P Arora, YS Marfatia, R Begum Decreased regulatory T-cells and CD4(+) /CD8(+) ratio correlate with disease onset and progression in patients with generalized vitiligo Pigment Cell Melanoma Res 26 2013 586 591
60. GK Naughton, M Eisinger, JC Bystryn Antibodies to normal human melanocytes in vitiligo J Exp Med 158 1983 246 251
61. GK Naughton, M Eisinger, JC Bystryn Detection of antibodies to melanocytes in vitiligo by specific immunoprecipitation J Invest Dermatol 81 1983 540 542
62. GK Naughton, D Reggiardo, JC Bystryn Correlation between vitiligo antibodies and extent of depigmentation in vitiligo J Am Acad Dermatol 15 1986 978 981
63. J Cui, Y Arita, JC Bystryn Cytolytic antibodies to melanocytes in vitiligo J Invest Dermatol 100 1993 812 815
64. R Harning, J Cui, JC Bystryn Relation between the incidence and level of pigment cell antibodies and disease activity in vitiligo J Invest Dermatol 97 1991 1078 1080
65. EH Kemp, NG Gavalas, DJ Gawkrodger, AP Weetman Autoantibody responses to melanocytes in the depigmenting skin disease vitiligo Autoimmun Rev 6 2007 138 142
66. TM Kroll, H Bommiasamy, RE Boissy et al. 4-Tertiary butyl phenol exposure sensitizes human melanocytes to dendritic cell-mediated killing: relevance to vitiligo J Invest Dermatol 124 2005 798 806
67. Y Gauthier, M Cario Andre, A Taïeb A critical appraisal of vitiligo etiologic theories. Is melanocyte loss a melanocytorrhagy? Pigment Cell Res 16 2003 322 332
68. Y Gauthier, M Cario-Andre, S Lepreux, C Pain, A Taïeb Melanocyte detachment after skin friction in non lesional skin of patients with generalized vitiligo Br J Dermatol 148 2003 95 101
69. KU Schallreuter, JM Wood, J Berger Low catalase levels in the epidermis of patients with vitiligo J Invest Dermatol 97 1991 1081 1085
70. KU Schallreuter, JM Wood, I Ziegler et al. Defective tetrahydrobiopterin and catecholamine biosynthesis in the depigmentation disorder vitiligo Biochim Biophys Acta 1226 1994 181 192
71. G Weiss, A Shemer, H Trau The Koebner phenomenon: review of the literature J Eur Acad Dermatol Venereol 16 2002 241 248
72. Y Gauthier The importance of Koebner's phenomenon in the induction of vitiligo vulgaris lesions Eur J Dermatol 5 1995 704 708
73. N van Geel, R Speeckaert, A Taieb the VETF members Koebner's phenomenon in vitiligo: European position paper Pigment Cell Melanoma Res 24 2011 564 573
74. A Diallo, K Boniface, T Jouary et al. Development and validation of the K-VSCOR for scoring Koebner's phenomenon in vitiligo/non-segmental vitiligo Pigment Cell Melanoma Res 26 2013 402 407
75. P Kostopoulou, T Jouary, B Quintard et al. Objective vs. subjective factors in the psychological impact of vitiligo: the experience from a French referral centre Br J Dermatol 161 2009 128 133
76. E Lilly, PD Lu, JH Borovicka et al. Development and validation of a vitiligo-specific quality-of-life instrument (VitiQoL) J Am Acad Dermatol 69 2013 e11 e18
77. DJ Gawkrodger, AD Ormerod, L Shaw the Therapy Guidelines and Audit Subcommittee British Association of Dermatologists the Clinical Standards Department Royal College of Physicians of London the Cochrane Skin Group the Vitiligo Society Guideline for the diagnosis and management of vitiligo Br J Dermatol 159 2008 1051 1076
78. ME Whitton, DM Ashcroft, CW Barrett, U Gonzalez Interventions for vitiligo Cochrane Database Syst Rev 1 2006 CD003263.
79. DJ Gawkrodger, AD Ormerod, L Shaw et al. Vitiligo: concise evidence based guidelines on diagnosis and management Postgrad Med J 86 2010 466 471
80. ME Whitton, M Pinart, J Batchelor, C Lushey, J Leonardi-Bee, U González Interventions for vitiligo Cochrane Database Syst Rev 1 2010 CD003263.
81. A Taieb, A Alomar, M Böhm the Vitiligo European Task Force (VETF) the European Academy of Dermatology and Venereology (EADV) the Union Européenne des Médecins Spécialistes (UEMS) Guidelines for the management of vitiligo: the European Dermatology Forum consensus Br J Dermatol 168 2013 5 19
82. W Westerhof, L Nieuweboer-Krobotova Treatment of vitiligo with UV-B radiation vs topical psoralen plus UV-A Arch Dermatol 133 1997 1525 1528
83. A Singh, AJ Kanwar, D Parsad, R Mahajan Randomized controlled study to evaluate the effectiveness of dexamethasone oral minipulse therapy versus oral minocycline in patients with active vitiligo vulgaris Indian J Dermatol Venereol Leprol 80 2014 29 35
84. MD Njoo, W Westerhof, JD Bos, PM Bossuyt A systematic review of autologous transplantation methods in vitiligo Arch Dermatol 134 1998 1543 1549
85. N van Geel, BK Goh, E Wallaeys, S De Keyser, J Lambert A review of non-cultured epidermal cellular grafting in vitiligo J Cutan Aesthet Surg 4 2011 17 22
86. N van Geel, E Wallaeys, BK Goh, M De Mil, J Lambert Long-term results of noncultured epidermal cellular grafting in vitiligo, halo naevi, piebaldism and naevus depigmentosus Br J Dermatol 163 2010 1186 1193
87. R Falabella Surgical treatment of vitiligo: why, when and how J Eur Acad Dermatol Venereol 17 2003 518 520
88. MD Njoo, RM Vodegel, W Westerhof Depigmentation therapy in vitiligo universalis with topical 4-methoxyphenol and the Q-switched ruby laser J Am Acad Dermatol 42 2000 760 769
89. YJ Kim, BS Chung, KC Choi Depigmentation therapy with Q-switched ruby laser after tanning in vitiligo universalis Dermatol Surg 27 2001 969 970
90. J Rao, RE Fitzpatrick Use of the Q-switched 755-nm alexandrite laser to treat recalcitrant pigment after depigmentation therapy for vitiligo Dermatol Surg 30 2004 1043 1045
91. D Gupta, R Kumari, DM Thappa Depigmentation therapies in vitiligo Indian J Dermatol Venereol Leprol 78 2012 49 58
92. KM AlGhamdi, A Kumar Depigmentation therapies for normal skin in vitiligo universalis J Eur Acad Dermatol Venereol 25 2011 749 757
93. V Brazzelli, M Antoninetti, S Palazzini, T Barbagallo, A De Silvestri, G Borroni Critical evaluation of the variants influencing the clinical response of vitiligo: study of 60 cases treated with ultraviolet B narrow-band phototherapy J Eur Acad Dermatol Venereol 21 2007 1369 1374
94. V Eleftheriadou, ME Whitton, DJ Gawkrodger the vitiligo priority setting partnership Future research into the treatment of vitiligo: where should our priorities lie? Results of the vitiligo priority setting partnership Br J Dermatol 164 2011 530 536
95. J Porter, A Beuf, JJ Nordlund, AB Lerner Personal responses of patients to vitiligo: the importance of the patient-physician interaction Arch Dermatol 114 1978 1384 1385
96. D Parsad, S Dogra, AJ Kanwar Quality of life in patients with vitiligo Health Qual Life Outcomes 1 2003 58
97. M Sukan, F Maner The problems in sexual functions of vitiligo and chronic urticaria patients J Sex Marital Ther 33 2007 55 64
98. J Porter, AH Beuf, JJ Nordlund, AB Lerner Psychological reaction to chronic skin disorders: a study of patients with vitiligo Gen Hosp Psychiatry 1 1979 73 77
99. LS Nogueira, PC Zancanaro, RD Azambuja Vitiligo and emotions An Bras Dermatol 84 2009 41 45 (in English, Portuguese).
100. G Schmid-Ott, HW Künsebeck, E Jecht et al. Stigmatization experience, coping and sense of coherence in vitiligo patients J Eur Acad Dermatol Venereol 21 2007 456 461
101. N Talsania, B Lamb, A Bewley Vitiligo is more than skin deep: a survey of members of the Vitiligo Society Clin Exp Dermatol 35 2010 736 739
102. MW Linthorst Homan, J de Korte, MA Grootenhuis, JD Bos, MA Sprangers, JP van der Veen Impact of childhood vitiligo on adult life Br J Dermatol 159 2008 915 920
103. L Borimnejad, Z Parsa Yekta, A Nikbakht-Nasrabadi, A Firooz Quality of life with vitiligo: comparison of male and female Muslim patients in Iran Gend Med 3 2006 124 130
104. L Papadopoulos, R Bor, C Legg Coping with the disfiguring effects of vitiligo: a preliminary investigation into the effects of cognitive-behavioural therapy Br J Med Psychol 72 1999 385 396
105. L Papadopoulos, R Bor, C Legg, JL Hawk Impact of life events on the onset of vitiligo in adults: preliminary evidence for a psychological dimension in aetiology Clin Exp Dermatol 23 1998 243 248
106. V Eleftheriadou, KS Thomas, ME Whitton, JM Batchelor, JC Ravenscroft Which outcomes should we measure in vitiligo? Results of a systematic review and a survey among patients and clinicians on outcomes in vitiligo trials Br J Dermatol 167 2012 804 814
107. U González, M Whitton, V Eleftheriadou, M Pinart, J Batchelor, J Leonardi-Bee Guidelines for designing and reporting clinical trials in vitiligo Arch Dermatol 147 2011 1428 1436
108. V Eleftheriadou Future horizons in vitiligo research: focusing on the recommendations of the Cochrane systematic review 'Interventions for vitiligo' 2010 Br J Dermatol 169 suppl 3 2013 67 70
109. K Cowan, S Oliver The James Lind Alliance guidebook 2010 James Lind Alliance Southampton
110. UK Dermatology Clinical Trials Network Trials in development. Bewley A. Is psychological intervention better than standard care alone in the management of vitiligo? http://www.ukdctn.org/trials/development (accessed Oct 1, 2014).
111. V Eleftheriadou, K Thomas, J Ravenscroft, M Whitton, J Batchelor, H Williams Feasibility, double-blind, randomised, placebo-controlled, multi-centre trial of hand-held NB-UVB phototherapy for the treatment of vitiligo at home (HI-Light trial: home intervention of light therapy) Trials 15 2014 51
112. Centre of Evidence Based Dermatology National Institute for Health Research Programme Grant http://www.nottingham.ac.uk/research/groups/cebd/projects/nihr-programme-grant.aspx (accessed Sept 26, 2014).
113. Centre of Evidence Based Dermatology Pilot HI-Light trial for the treatment of early/focal vitiligo http://www.nottingham.ac.uk/research/groups/cebd/projects/2vitiligo/hi-light-pilot-trial-for-vitiligo.aspx (accessed Sept 26, 2014).
114. Centre of Evidence Based Dermatology Training: how to use hand-held light therapy for vitiligo http://www.nottingham.ac.uk/research/groups/cebd/videos/training-vitiligo.aspx (accessed Sept 26, 2014).
115. SK Tour, KS Thomas, DM Walker, P Leighton, AS Yong, JM Batchelor Survey and online discussion groups to develop a patient-rated outcome measure on acceptability of treatment response in vitiligo BMC Dermatol 14 2014 10
116. M Rashighi, P Agarwal, JM Richmond et al. CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo Sci Transl Med 6 2012 223ra23
117. A Bertolotti, K Boniface, B Vergier et al. Type I interferon signature in the initiation of the immune response in vitiligo Pigment Cell Melanoma Res 27 2014 398 407
118. JE Harris, TH Harris, W Weninger, EJ Wherry, CA Hunter, LA Turka A mouse model of vitiligo with focused epidermal depigmentation requires IFN-γ for autoreactive CD8+ T-cell accumulation in the skin J Invest Dermatol 132 2012 1869 1876
119. ML Dell'anna, M Picardo A review and a new hypothesis for non-immunological pathogenetic mechanisms in vitiligo Pigment Cell Res 19 2006 406 411